Tirzepatide Tirzepatide is a once-a-week injection that helps with long-term weight management when combined with healthy eating and regular physical activity
3-6 Months: Maximum Benefits The 3-6 month period generally brings the most substantial results: Clinical trials show that patients lost 10-15% of their initial body weight on average Many patients report improved energy levels and mobility Health markers like blood pressure and blood sugar often show significant improvement Body composition changes become more apparent Physical activity typically becomes easier and more enjoyable During this period, the combined effects of weight loss, improved metabolic health and established healthy habits often create momentum that helps maintain long-term success
Bottom Line Despite some dizzying progress for this class of drugs, there are still so many unknowns (besides lack of explainability as already touched on)
784 Ten-year data from a single-center RCT in Italy showed that 37.5% participants randomized to a surgical intervention maintained DM remission (25% for Roux-en-Y gastric bypass and 50% for biliopancreatic diversion) compared with 5.5% of participants treated with medical therapy
We believe this is just the beginning of a broader shift in how GLP-1 treatments are priced and delivered across the country, and we'll keep working to make sure every Canadian has access to the care they deserve
The tirzepatide dosing guide walks through a similar escalation pattern